Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass

Ann Vasc Surg. 2011 Aug;25(6):840.e9-12. doi: 10.1016/j.avsg.2010.12.040. Epub 2011 May 28.

Abstract

Heparin-induced thrombocytopenia type II is an immune-mediated syndrome that may arise in a time-dependent manner after heparin therapy. Thrombocytopenia and thrombosis in patients exposed to heparin are suggestive of this syndrome.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Arginine / analogs & derivatives
  • Arterial Occlusive Diseases / surgery*
  • Blood Vessel Prosthesis Implantation / adverse effects*
  • Blood Vessel Prosthesis Implantation / instrumentation
  • Blood Vessel Prosthesis*
  • Coated Materials, Biocompatible*
  • Device Removal
  • Early Diagnosis
  • Female
  • Heparin / administration & dosage
  • Heparin / adverse effects*
  • Humans
  • Lower Extremity / blood supply*
  • Pipecolic Acids / administration & dosage
  • Polytetrafluoroethylene
  • Prosthesis Design
  • Reoperation
  • Sulfonamides
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / therapy
  • Treatment Outcome

Substances

  • Anticoagulants
  • Coated Materials, Biocompatible
  • Pipecolic Acids
  • Sulfonamides
  • Polytetrafluoroethylene
  • Heparin
  • Arginine
  • argatroban